We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Integrated Range of Solutions Designed for Preclinical Research Informatics

By LabMedica International staff writers
Posted on 28 May 2012
A platform has been developed that provides for registering, analyzing, and managing scientific data, an electronic laboratory notebook for chemistry and biology experiments, the ability to query and report research data, and to visualize with chemical intelligence.

Dotmatics, Ltd. (Bishops Stortford, UK), a provider of informatics services to the pharmaceutical and biotechnology industries, reported that Basilea Pharmaceutica International, Ltd. (Basel, Switzerland) have licensed and globally deployed Dotmatics’ entire range of scientific informatics solutions for preclinical research data management.

Basilea CSO, Laurenz Kellenberger, PhD, stated, “With the integrated Dotmatics platform tailored to Basilea’s specific needs, we are further enhancing the way we globally consolidate and learn from biological and chemical research data. We look forward to continue working with Dotmatics to efficiently address our future informatics requirements in chemistry and biology.”

“We are really excited to have this opportunity to provide a suite of tools for global deployment in Basilea’s research group and to be able to collaborate with them,” said Stephen Gallagher, PhD, and CEO of Dotmatics. “We are committed to delivering high quality solutions and services to ensure that the informatics requirements of Basilea’s R & D are fulfilled.”

Dotmatics has rapidly emerged as a preferred informatics supplier to many of the top global pharmaceutical, biotechnology, and academic organizations. The company is a scientific software firm deploying web-based knowledge solutions that improve the way scientific data is queried, managed, and shared within companies. Dotmatics has expertise in chem- and bioinformatics techniques including chemical databases, SAR analysis, data management, and data visualization.

Solution highlights include (1) Browser--a Web-based tool for querying, browsing, and visualizing biologic databases such as IDBS’ ActivityBase and any chemical database. (2) Vortex--a visualization and analytics platform for scientific and non-scientific data. (3) D40- Chemistry enabling MS Office. (4) Bioregister--a web-based tool for registering biologic entities. (5) Gateway, a securely enables research teams to share data internally and with external partners. (6) Pinpoint, a powerful Oracle chemical cartridge for querying and integrating chemical databases (Pinpoint was developed in collaboration with Astex Therapeutics, Ltd. [Dublin, CA, USA]) Pinpoint represents excellent indexing and search performance at a cost-effective price. (7) Register--a flexible and scalable chemical registration system. (8) Nucleus--a map and import biologic and nonbiologic data files into an Oracle database. (9) Studies--a new standard in screening data management. (10) Lastly, Studies Notebook--a web-based, electronic lab notebook (ELN) designed for all disciplines.

Basilea Pharmaceutica Ltd. is a company focused on research, development, and commercialization of drugs that address the medical challenge of rising resistance and non-response to current treatment options in the hospital and specialty care setting in the areas of bacterial and fungal infections, oncology, and skin diseases.

Related Links:

Dotmatics
Basilea Pharmaceutica International






New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
LH ELISA
Luteinizing Hormone ELISA

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries